New dosing method aims to make statins safer for liver patients
NCT ID NCT07459972
First seen Mar 23, 2026 · Last updated May 01, 2026 · Updated 5 times
Summary
This study tested a computer-guided method to find the right dose of simvastatin for people with liver cirrhosis and high blood pressure in the liver (portal hypertension). Twenty-two adults with mild to moderate cirrhosis took part. The goal was to see if this personalized dosing could improve blood flow in the liver and reduce side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kafrelsheikh University
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.